Alosetron Hydrochloride Patent Expiration
Alosetron Hydrochloride is Used for treating severe diarrhea-predominant irritable bowel syndrome (IBS) in women. It was first introduced by Legacy Pharma Inc
Alosetron Hydrochloride Patents
Given below is the list of patents protecting Alosetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lotronex | US6284770 | Medicaments for the treatment of non-constipated female irritable bowel syndrome |
Oct 05, 2018
(Expired) | Legacy Pharma |
| Lotronex | US5360800 | Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives |
Jan 13, 2013
(Expired) | Legacy Pharma |
Alosetron Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List